Cargando…

Innovation in Regulatory Science Is Meeting Evolution of Clinical Evidence Generation

At the turn of the century, the pharmaceutical industry began a transition toward a focus on oncology, rare diseases, and other areas of high unmet need that required a new, more complex approach to drug development. For many of these disease states and novel approaches to therapy, traditional appro...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Myrto, Ly, Hoan, Möller, Clemens C., Ringel, Michael S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593618/
https://www.ncbi.nlm.nih.gov/pubmed/30636288
http://dx.doi.org/10.1002/cpt.1354

Ejemplares similares